{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:34:59Z","timestamp":1792564499915,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Nonexpandable lung is a recognized phenomenon that can create management challenges in patients with mesothelioma. Its prevalence and clinical importance are unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study was to describe the prevalence of nonexpandable lung and to evaluate whether there was any association between nonexpandable lung and survival in a clinical cohort of patients with mesothelioma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a prospective, observational cohort study of patients with mesothelioma who were seen in a single center between March 1, 2008, and August 3, 2017. Baseline characteristics were collected at diagnosis. Serial chest radiographs were assessed for the presence of pleural effusions and nonexpandable lung (defined as a lack of lung expansion after pleural aspiration or drainage). Patients were followed until they died or were censored on March 14, 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 229 patients, 192 (82.7%) had a pleural effusion at presentation, and nonexpandable lung was observed in 64 of these 192 patients (33.3%). Breathlessness and cough were more frequent in patients with pleural effusions, especially in those with underlying nonexpandable lung, whereas chest pain was more prevalent in patients without effusions. Patients with pleural effusions, both with and without underlying nonexpandable lung, were more likely to have epithelioid or early-stage disease and to receive chemotherapy than patients with no pleural effusion. Nonexpandable lung was an independent risk factor for short survival, with a hazard ratio for mortality of 1.80 (95% confidence interval, 1.16\u20132.80) compared with patients without nonexpandable lung. The presence of a pleural effusion did not appear to be associated with a worse prognosis compared with patients with an effusion (adjusted hazard ratio, 1.86; 95% confidence interval, 0.93\u20133.72).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first study to describe the prevalence and clinical implications of nonexpandable lung in mesothelioma. It demonstrates that nonexpandable lung is a relatively common phenomenon that is associated with significant symptomatology and shorter survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201811-786oc","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T18:26:00Z","timestamp":1560363960000},"page":"1273-1279","source":"Crossref","is-referenced-by-count":32,"title":["The Prevalence and Clinical Relevance of Nonexpandable Lung in Malignant Pleural Mesothelioma. A Prospective, Single-Center Cohort Study of 229 Patients"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-7754","authenticated-orcid":false,"given":"Anna C.","family":"Bibby","sequence":"first","affiliation":[{"name":"Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom; and"},{"name":"North Bristol Lung Centre, North Bristol NHS Trust, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Halford","sequence":"additional","affiliation":[{"name":"Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-9671","authenticated-orcid":false,"given":"Duneesha","family":"De Fonseka","sequence":"additional","affiliation":[{"name":"Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom; and"},{"name":"North Bristol Lung Centre, North Bristol NHS Trust, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna J.","family":"Morley","sequence":"additional","affiliation":[{"name":"North Bristol Lung Centre, North Bristol NHS Trust, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Smith","sequence":"additional","affiliation":[{"name":"North Bristol Lung Centre, North Bristol NHS Trust, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1276-6500","authenticated-orcid":false,"given":"Nick A.","family":"Maskell","sequence":"additional","affiliation":[{"name":"Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom; and"},{"name":"North Bristol Lung Centre, North Bristol NHS Trust, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"2026012203395354500_bib1","volume-title":"Effects of health of exposure to asbestos. Health & Safety Commission","author":"Doll"},{"key":"2026012203395354500_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026012203395354500_bib3","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2017-211321","article-title":"British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma","volume":"73","author":"Woolhouse","year":"2018","journal-title":"Thorax"},{"key":"2026012203395354500_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","article-title":"Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales","volume":"88","author":"Beckett","year":"2015","journal-title":"Lung Cancer"},{"key":"2026012203395354500_bib5","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"2026012203395354500_bib6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000321370","article-title":"A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma","volume":"80","author":"Tanrikulu","year":"2010","journal-title":"Respiration"},{"key":"2026012203395354500_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/thx.52.6.507","article-title":"Malignant mesothelioma in south east England: clinicopathological experience of 272 cases","volume":"52","author":"Yates","year":"1997","journal-title":"Thorax"},{"key":"2026012203395354500_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/cncr.20315","article-title":"Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: using the LCSS-Meso conceptual model for validation","volume":"101","author":"Hollen","year":"2004","journal-title":"Cancer"},{"key":"2026012203395354500_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0002-9343(80)90103-5","article-title":"Multimodality therapy for malignant mesothelioma based on a study of natural history","volume":"68","author":"Antman","year":"1980","journal-title":"Am J Med"},{"key":"2026012203395354500_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ajcp\/65.5.583","article-title":"Diffuse malignant mesothelioma","volume":"65","author":"Klima","year":"1976","journal-title":"Am J Clin Pathol"},{"key":"2026012203395354500_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1378\/chest.60.6.564","article-title":"Diffuse malignant mesothelioma of the pleura: a review of 37 cases","volume":"60","author":"Oels","year":"1971","journal-title":"Chest"},{"key":"2026012203395354500_bib12","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/1097-0142(19820601)49:11<2431::AID-CNCR2820491134>3.0.CO;2-W","article-title":"Malignant mesothelioma of the pleura: review of 123 patients","volume":"49","author":"Brenner","year":"1982","journal-title":"Cancer"},{"key":"2026012203395354500_bib13","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/1097-0142(19861001)58:7<1540::AID-CNCR2820580727>3.0.CO;2-5","article-title":"Diffuse malignant mesothelioma of pleura. Diagnosis and survival in 92 cases","volume":"58","author":"Adams","year":"1986","journal-title":"Cancer"},{"key":"2026012203395354500_bib14","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/1097-0142(197612)38:6<2481::AID-CNCR2820380637>3.0.CO;2-9","article-title":"Pleural mesothelioma","volume":"38","author":"Wanebo","year":"1976","journal-title":"Cancer"},{"key":"2026012203395354500_bib15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B","volume":"113","author":"Herndon","year":"1998","journal-title":"Chest"},{"key":"2026012203395354500_bib16","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/bjc.2013.504","article-title":"Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma","volume":"109","author":"Meniawy","year":"2013","journal-title":"Br J Cancer"},{"key":"2026012203395354500_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/096992603322731143","article-title":"Suffering in mesothelioma: concepts and contexts","volume":"11","author":"Clayson","year":"2003","journal-title":"Prog Palliat Care"},{"key":"2026012203395354500_bib18","first-page":"458","article-title":"Living with mesothelioma. A literature review","volume":"19","author":"Moore","year":"2010","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2026012203395354500_bib19","doi-asserted-by":"crossref","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J"},{"issue":"5","key":"2026012203395354500_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(18)30421-1","article-title":"Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial","volume":"7","author":"Lentz","year":"2019","journal-title":"The Lancet Respiratory Medicine"},{"key":"2026012203395354500_bib21","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1378\/chest.13-2876","article-title":"Novel use of pleural ultrasound can identify malignant entrapped lung prior to effusion drainage","volume":"146","author":"Salamonsen","year":"2014","journal-title":"Chest"},{"key":"2026012203395354500_bib22","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"2026012203395354500_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3410\/M2-77","article-title":"The unexpandable lung","volume":"2","author":"Huggins","year":"2010","journal-title":"F1000 Med Rep"},{"key":"2026012203395354500_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1752-699X.2011.00254.x","article-title":"Outcomes and complications following medical thoracoscopy","volume":"6","author":"Brims","year":"2012","journal-title":"Clin Respir J"},{"key":"2026012203395354500_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012203395354500_bib26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5","article-title":"Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging","volume":"72","author":"Boutin","year":"1993","journal-title":"Cancer"},{"key":"2026012203395354500_bib27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","article-title":"A proposed new international TNM staging system for malignant pleural mesothelioma","volume":"108","author":"Rusch","year":"1995","journal-title":"Chest"},{"key":"2026012203395354500_bib28","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","article-title":"High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy","volume":"16","author":"Kao","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2026012203395354500_bib29","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"The ASAP trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203395354500_bib30","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1378\/chest.119.6.1641","article-title":"Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion","volume":"119","author":"Pien","year":"2001","journal-title":"Chest"},{"key":"2026012203395354500_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1378\/chest.08-1788","article-title":"Assessment of pleural pressure in the evaluation of pleural effusions","volume":"135","author":"Feller-Kopman","year":"2009","journal-title":"Chest"},{"key":"2026012203395354500_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/resp.12426","article-title":"Cough during therapeutic thoracentesis: friend or foe?","volume":"20","author":"Zielinska-Krawczyk","year":"2015","journal-title":"Respirology"},{"key":"2026012203395354500_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/021849230801600208","article-title":"Management of malignant pleural effusion associated with trapped lung syndrome","volume":"16","author":"Qureshi","year":"2008","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"2026012203395354500_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J Clin Oncol"},{"key":"2026012203395354500_bib35","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"Flores","year":"2007","journal-title":"J Thorac Oncol"},{"key":"2026012203395354500_bib36","doi-asserted-by":"crossref","first-page":"e0145039","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: a Surveillance, Epidemiology, and End Results (SEER) study of 14,228 patients","volume":"10","author":"Taioli","year":"2015","journal-title":"PLoS One"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/16\/10\/1273\/66382318\/annalsats_16_10_1273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/16\/10\/1273\/66382318\/annalsats_16_10_1273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:43:55Z","timestamp":1769071435000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/16\/10\/1273\/8423512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,1]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201811-786oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2019,10,1]]}}}